Table 1.
Variables | Body Mass Index (BMI) | p | |||
---|---|---|---|---|---|
Normal Weight n = 53 |
Overweight n = 92 |
Obese n = 47 |
|||
Patient’s characteristics and pregnancy-related complications | |||||
Age, MV ± SD (95% CI) |
30.66 ± 4.98 (29.29–32.02) |
30.51 ± 5.53 (29.36–31.66) |
31.06 ± 5.42 (29.47–32.66) |
0.847 c | |
Positive family history for CVD, N (%) | 11 (20.8%) | 22 (23.9%) | 20 (42.6%) | 0.028 b | |
Gestational hypertension, N (%) |
2 (3.8%) | 9 (9.8%) | 11 (23.4%) | 0.007 b | |
Gestational diabetes mellitus, N (%) | 2 (3.8%) | 6 (6.5%) | 6 (12.8%) | 0.209 b | |
Primary thrombophilia, N (%) | 2 (3.8%) | 8 (8.7%) | 2 (4.3%) | 0.413 b | |
Anemia, N (%) | 15 (28.3%) | 36 (39.1%) | 20 (42.6%) | 0.283 b | |
Gestational age at labor, median (variance) |
38 weeks and 5 days (1678.5) |
39 weeks and 1 day (288.7) |
38 weeks and 1 day (541.8) |
0.323 a | |
Pregnancy outcome, N (%) |
Live birth | 49 (92.4%) | 88 (95.65%) | 41 (87.2%) | 0.008 b |
Stillbirth | 1 (1.9%) | 4 (4.35%) | 6 (12.8%) | ||
Miscarriage | 3 (5.7%) | 0 (0%) | 0 (0%) | ||
Newborn’s characteristics | |||||
Live newborns, N (%) |
Pre-term | 17 (34.7%) | 19 (21.6%) | 11 (26.8%) | 0.474 b |
Term | 32 (65.3%) | 68 (77.3%) | 30 (73.2%) | ||
Post-term | 0 (0%) | 1 (1.1%) | 0 (0%) | ||
Amniotic fluid index, median (variance) |
120.00 (751.7) |
120.00 (1141.4) |
130 (2033.4) |
0.139 a | |
Placenta maturity grade, median (variance) |
2.50 (0.9) |
3.00 (0.8) |
3.00 (0.5) |
0.041 a | |
Intrauterine growth restriction, N (%) | 3 (5.8%) | 4 (4.5%) | 1 (2.2%) | 0.674 b | |
Large for gestational age, N (%) | 0 (0.0%) | 2 (2.2%) | 3 (6.5%) | 0.128 b | |
Apgar score 1st minute, median (variance) |
9.00 (8.5) |
9.00 (4.5) |
9.00 (10.1) |
0.500 a | |
Apgar score 5th minute, median (variance) |
10.00 (9.8) |
10.00 (5.5) |
10.00 (12.2) |
0.807 a |
a Kruskal–Wallis test; b chi square test; c ANOVA test; CVD—cardiovascular disease; MV—mean value; SD—standard deviation; CI—confidence interval.